Clinical Trial

Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.

Name: Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial. — clinical trial record (NCT06989099)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To learn if reconstruction of the lymphatic system at the time of axillary lymphadenectomy can reduce the risk of developing lymphedema.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-05-23; most recent amendment 2026-02-17.

Trial Details

NCT Number	NCT06989099
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Lymphedema
Enrollment	50 participants
Start Date	2024-09-24
Primary Completion	2028-08-01 (estimated)
Study Completion	2029-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-19